Defensive stocks show deep value as cyclicals run hot, UBS says
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
- Nasdaq futures slip as tech rally pauses ahead of Warsh's speech
- Oil holds steady, on track for weekly fall on US-Iran talks stalemate
- Dollar heads for weekly gain as Warsh remarks awaited
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
- Ovintiv adds 41,000 acres in Permian and Montney deals
- Russia says it could strike UK military targets in response to Kyiv's use of British missiles
Boston Scientific (BSX) PT Raised to $132 at Canaccord Genuity
October 1, 2025 4:10 AM EDTCanaccord Genuity analyst William Plovanic raised the price target on Boston Scientific (NYSE: BSX) to $132.00 (from $131.00) while maintaining a Buy rating.
The analyst comments "Bottom line: BSX outlined its forward growth strategies at its 2025 Investor Day, where the company showed that over the 2026E-2028E period, it expects to continue to... More
